Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chugai
Biotech
Roche's Chugai inks Swiss ADC deal potentially worth over $780M
Chugai will fully fund Zurich-based Araris Biotech's efforts to develop new antibody-drug conjugates.
Darren Incorvaia
Jan 8, 2025 8:00am
Biofourmis, Chugai team up on measuring endometriosis pain
Jul 22, 2020 11:38am
Verastem pens KRAS-focused drug licensing deal with Chugai
Jan 8, 2020 9:20am
Viela Bio, China's Hansoh pen $220M-plus development deal
May 28, 2019 10:58am
Chugai ponies up $1B+ to combine R&D in Yokohama
May 22, 2019 10:33am
Chugai preps filings for Soliris rival in rare disease
Dec 19, 2018 10:05am
